You are here


Recent Headlines

Insuring Against a Data Breach: Are Cyber-liability Policies Worth the Premiums?

Understanding risks, policy costs and potential value can help you decide whether to invest in cyber-liability insurance.

Rethinking Resource Allocation: WannaCry Shakes up Health IT & Device Makers

While the WannaCry cyberattack against hospitals, clinics and device makers was largely unsuccessful, future hacks might be used to imperil patients. Experts worry the U.S system is still too vulnerable and health IT departments are under-resourced.  

Value-based Reimbursement Is Here to Stay & Other Lessons from Cath Lab Leadership Boot Camp

The business of cardiology was at the forefront of discussion at the Society for Cardiovascular Angiography and Interventions (SCAI) Cath Lab Leadership Boot Camp in May. Speakers focused on the Medicare Access and CHIP Reauthorization Act of 2015 (MACRA), bundled payment models and value-based reimbursement. Here are a few of the lessons attendees took back to their practices.

Cost-minded Hospitals Give CTO PCI a Second Look

Questions have swirled around the value of percutaneous coronary intervention (PCI) for patients whose quality of life has suffered from chronic total occlusion (CTO). Inevitably, another issue has arisen: which cath labs and operators should be undertaking these difficult and costly procedures?

Walk this way: Robotic suit to help stroke patients recover movement

For stroke survivors, recovering physical abilities often involves relearning how to walk. To help, researchers at Boston University’s College of Health and Rehabilitation Sciences have developed an “exosuit” to support a patient’s movements.

FDA agrees to review Amgen’s PCSK9 inhibitor

Biotechnology company Amgen has received priority review from the U.S. Food and Drug Administration (FDA) for its PCSK9 inhibitor, Repatha.

FDA recalls Penumbra stent retrieving system

Penumbra Inc. is recalling its Penumbra 3D Revascularization device due to a risk of delivery wire breakage or separation during use, according to a July 21 U.S. Food and Drug Administration (FDA) release.

Virtual reality allows surgeons into the hearts of conjoined twins

Healthcare is just beginning to realize the potential of virtual reality, but for two conjoined sisters in Minnesota, the technology couldn't have done more. Paisleigh and Paislyn Martinez survived a highly risky nine-hour surgery to separate the two who were attached in the chest and torso areas.

Two Biotronik ICD systems receive FDA approval

Two implantable cardioverter defibrillator (ICD) systems made by Biotronik were approved by the U.S. Food and Drug Administration, the company announced July 19.

AliveCor, Mayo work to develop technology to detect congenital heart condition

Mountain View, California-based AliveCor, which makes the personal electrocardiogram, Kardia Mobile, has plans to enhance the device with a new detection feature through a collaboration with Mayo Clinic.